N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 2882372)

Published in BMC Microbiol on May 12, 2010

Authors

Tiemei Zhao1, Youning Liu

Author Affiliations

1: Department of Respiratory diseases, Chinese PLA General Hospital, Beijing, China.

Articles citing this

The potential role of N-acetylcysteine for the treatment of Helicobacter pylori. J Clin Gastroenterol (2011) 0.92

Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum. EBioMedicine (2015) 0.91

Role of biofilm in children with recurrent upper respiratory tract infections. Eur J Clin Microbiol Infect Dis (2014) 0.89

Antiadhesive activity of the biosurfactant pseudofactin II secreted by the Arctic bacterium Pseudomonas fluorescens BD5. BMC Microbiol (2012) 0.88

Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa. Microbiologyopen (2013) 0.82

Antimicrobial activity of alexidine alone and associated with N-acetylcysteine against Enterococcus faecalis biofilm. Int J Oral Sci (2013) 0.80

Does dithiothreitol improve bacterial detection from infected prostheses? A pilot study. Clin Orthop Relat Res (2012) 0.79

Effect of Cinnamon Oil on Quorum Sensing-Controlled Virulence Factors and Biofilm Formation in Pseudomonas aeruginosa. PLoS One (2015) 0.78

N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism. Antimicrob Agents Chemother (2015) 0.78

2,3-dihydroxybenzoic acid-containing nanofiber wound dressings inhibit biofilm formation by Pseudomonas aeruginosa. Antimicrob Agents Chemother (2014) 0.78

Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus. PLoS One (2015) 0.78

Carvacrol codrugs: a new approach in the antimicrobial plan. PLoS One (2015) 0.76

N-acetylcysteine in agriculture, a novel use for an old molecule: focus on controlling the plant-pathogen Xylella fastidiosa. PLoS One (2013) 0.76

Exposed subcutaneous implantable devices: an operative protocol for management and salvage. Plast Reconstr Surg Glob Open (2015) 0.75

In Vitro Efficacy of Nonantibiotic Treatments on Biofilm Disruption of Gram-Negative Pathogens and an In Vivo Model of Infectious Endometritis Utilizing Isolates from the Equine Uterus. J Clin Microbiol (2015) 0.75

Flor Yeast: New Perspectives Beyond Wine Aging. Front Microbiol (2016) 0.75

In vitro efficacy of N-acetylcysteine on bacteria associated with chronic suppurative otitis media. J Otolaryngol Head Neck Surg (2014) 0.75

N-Acetyl-l-cysteine effects on multi-species oral biofilm formation and bacterial ecology. Lett Appl Microbiol (2015) 0.75

A novel adjunctive cleansing method to reduce colony-forming units on duodenoscopes. Endosc Int Open (2016) 0.75

Articles cited by this

Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol (2001) 11.67

Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology (2000) 11.05

Pathogenesis of cystic fibrosis. Lancet (1993) 3.34

Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS (2007) 2.82

Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease. Clin Infect Dis (2008) 2.27

Determination of MICs for Mycobacterium avium-M. intracellulare complex in liquid medium by a colorimetric method. J Clin Microbiol (1995) 1.96

Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa. Eur Respir J (1996) 1.68

Environmental conditions which influence mucoid conversion Pseudomonas aeruginosa PAO1. Infect Immun (1991) 1.62

Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax (2002) 1.59

Reproducibility of the microdilution checkerboard method for antibiotic synergy. Antimicrob Agents Chemother (1993) 1.46

Biofilms, antimicrobial resistance, and airway infection. N Engl J Med (2002) 1.46

The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J (2000) 1.37

Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. J Clin Microbiol (1977) 1.31

N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol (2003) 1.31

Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms. Int J Antimicrob Agents (2003) 1.26

Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother (1997) 1.15

The effect of Pseudomonas aeruginosa infection on clinical parameters in steady-state bronchiectasis. Chest (1998) 1.11

Quantitative assay of glycocalyx produced by viridans group streptococci that cause endocarditis. J Clin Microbiol (1989) 1.10

Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology (2007) 0.99

A prediction model for bacterial etiology in acute exacerbations of COPD. Infection (2007) 0.97

Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. J Antimicrob Chemother (2000) 0.93

Prevention of biofilm formation by dairy products and N-acetylcysteine on voice prostheses in an artificial throat. Acta Otolaryngol (2004) 0.91

N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: clinical score, spirometry and ciliary motility. Eur Respir J (1989) 0.90

Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces. Pol J Microbiol (2009) 0.90

N-acetylcysteine potentiates the anti-pseudomonas activity of carbenicillin in vitro. J Infect (1981) 0.89

[Correlation of endotracheal tube biofilm and recurrent ventilator-associated pneumonia with Pseudomonas aeruginosa]. Zhonghua Jie He He Hu Xi Za Zhi (2001) 0.79

Articles by these authors

Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease. Antimicrob Agents Chemother (2010) 1.73

The mutant selection window in rabbits infected with Staphylococcus aureus. J Infect Dis (2006) 1.25

An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia. Int J Infect Dis (2004) 1.11

Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review. J Antimicrob Chemother (2011) 0.96

Consensus for the management of severe acute respiratory syndrome. Chin Med J (Engl) (2003) 0.85

In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii. Antimicrob Agents Chemother (2010) 0.84

[The expression of AmpC and extended-spectrum beta-lactamases among clinical isolates of enterobacter cloacae and its impact on antibiotics susceptibility]. Zhonghua Yi Xue Za Zhi (2002) 0.80

Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir Res (2005) 0.80

Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge. Chest (2005) 0.79

Mycoplasma pneumoniae infection is associated with subacute cough. Eur Respir J (2013) 0.78

Sustained improvement of gas exchange and lung mechanics by vaporized perfluorocarbon inhalation in piglet acute lung injury model. Clin Respir J (2013) 0.77

Prospective multicenter study of pathogen distributions in early-onset and late-onset hospital-acquired pneumonia in china. Antimicrob Agents Chemother (2013) 0.75

Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.75

In vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo) (2011) 0.75

[Respiratory infection: a challenge we have to face]. Zhonghua Jie He He Hu Xi Za Zhi (2015) 0.75

[Respiratology]. Zhonghua Yi Xue Za Zhi (2002) 0.75

[Changes in the spectrum of the pathogens of community-acquired pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi (2002) 0.75

[Study on high-rate and low-rate metastatic large-cell lung cancer cell lines via differential display reverse transcript PCR]. Zhongguo Fei Ai Za Zhi (2003) 0.75

[Concerning about influenza prevention and treatment]. Zhonghua Jie He He Hu Xi Za Zhi (2002) 0.75

Antibacterial activities of nemonoxacin against clinical isolates of Staphylococcus aureus: an in vitro comparison with three fluoroquinolones. World J Microbiol Biotechnol (2014) 0.75

[What do we think of the off-label use of antibiotics]. Zhonghua Jie He He Hu Xi Za Zhi (2015) 0.75

In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii. J Chemother (2014) 0.75

[An experimental study of telomerase reverse transcriptase (hTERT) DNAzyme on growth of A549/DDP cells]. Zhongguo Fei Ai Za Zhi (2006) 0.75

Inhaling beta(2)-agonist with heliox-driven in bronchial asthma. Chin Med J (Engl) (2003) 0.75

Immediate hematological toxicity of linezolid in healthy volunteers with different body weight: a phase I clinical trial. J Antibiot (Tokyo) (2012) 0.75